Skip to content


Save 5%
Original price Rs.206.99
Current price Rs.196.64


Neoglip 50mg+50mg tablet belongs to class of anti-diabetics and is a combination of sitagliptin and metformin. Neoglip 50mg+50mg tablet is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes.


Neoglip 50mg+50mg tablet is indicated for the following:

Monotherapy: This medicine is used for treating type 2 diabetes (condition characterized by elevated glucose levels) that is inadequately controlled by metformin, diet and exercise.

Dual therapy: It is used for treating diabetes type 2 along with metformin or a glitazone when patients respond inadequately to diet changes, exercise and either metformin or glitazine, or in combination with sulphonylureas in patients contraindicated for metformin, and for patients that do not respond adequately to sulphonylureas alone.

Triple therapy: This medicine is used with metformin and a sulphonylureas or glitazone for treating diabetes 2 that is inadequately controlled by dual therapy.

With insulin: This medicine is used with or without metformin for treating type 2 diabetes in patients who respond inadequately to diet, exercise, and insulin.


Neoglip 50mg+50mg گولی درج ذیل کے لیے اشارہ کیا جاتا ہے:

مونوتھراپی: یہ دوا ٹائپ 2 ذیابیطس کے علاج کے لیے استعمال کی جاتی ہے (وہ حالت جس میں گلوکوز کی سطح بلند ہوتی ہے) جو کہ میٹفارمین، خوراک اور ورزش کے ذریعے ناکافی طور پر کنٹرول ہوتی ہے۔

دوہری تھراپی: یہ ذیابیطس ٹائپ 2 کے علاج کے لیے میٹفارمین یا گلیٹازون کے ساتھ استعمال کیا جاتا ہے جب مریض غذا میں تبدیلی، ورزش اور میٹفارمین یا گلیٹازائن کے لیے ناکافی ردعمل ظاہر کرتے ہیں، یا میٹفارمین کے لیے متضاد مریضوں میں سلفونی لوریز کے ساتھ مل کر، اور ایسے مریضوں کے لیے جو جواب نہیں دیتے۔ صرف سلفونی لوریز کے لیے کافی ہے۔

ٹرپل تھراپی: اس دوا کو میٹفارمین اور سلفونی لوریاس یا گلٹازون کے ساتھ ذیابیطس 2 کے علاج کے لیے استعمال کیا جاتا ہے جسے دوہری تھراپی سے ناکافی طور پر کنٹرول کیا جاتا ہے۔

انسولین کے ساتھ: یہ دوا ان مریضوں میں ٹائپ 2 ذیابیطس کے علاج کے لیے میٹفارمین کے ساتھ یا اس کے بغیر استعمال کی جاتی ہے جو خوراک، ورزش اور انسولین کے لیے ناکافی ردعمل دیتے ہیں۔




Neoglip 50mg+50mg tablet may cause nausea, vomiting, stomach upset, diarrhea, headache, or a metallic taste in the mouth may occur. A tablet may also appear in your stool.


Neoglip 50mg+50mg tablet is contraindicated in patients with known hypersensitivity to the drug.

The patients with diabetic ketoacidosis (condition causing fat breakdown at an abnormal rate) and moderate to severe renal (kidney) impairment should avoid use of this medicine.


Assess risk factors for lactic acidosis (buildup of lactate causing acidic pH of blood stream). Discontinue immediately if metabolic acidosis (overproduction of acid in the body) is suspected. Monitor renal (kidney) function at least annually. Discontinue the medicine for 48 hours before and after the elective surgery.


Neoglip 50mg+50mg tablet have interactions with other anti-diabetic agents and avoid concomitant use to avoid severe adverse effects related to it.


The recommended dose of Neoglip 50mg+50mg tablet is tow tablets daily a sper doctor recommendation.


Consult your doctor and discuss your queries related to any medicine or disease. EHAD PHARMACY's aim is to make sure that its consumers get material that is correct, reviewed by an expert, and error-free. However, the material stated here should not be used as a replacement for the advice of a qualified physician. The information given here is for informational purposes only, which may not cover all possible precautions, side effects, contraindications, or drug interactions.

Buy medicine online in Pakistan from the most trusted online pharmacy EHAD. Free delivery along with cash on delivery & up to 35% discount. Buy from EHAD Online Pharmacy, your medicine, mother care, baby care, personal care, healthcare supplements, and wellness products online. Give us a call to order medicine at +92 334 1113423.

Belongs to the category: Diabetes medicines, Type 2